Arcadia Biosciences Analyst Ratings
Arcadia Biosciences Analyst Ratings
While ratings are subjective and will change, the latest Arcadia Biosciences (RKDA) rating was a reiterated with a price target of $0.00 to $15.00. The current price Arcadia Biosciences (RKDA) is trading at is $5.43, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/24/2023 | 176.24% | HC Wainwright & Co. | → $15 | Reiterates | Buy → Buy |
| 06/05/2023 | 176.24% | HC Wainwright & Co. | $18 → $15 | Maintains | Buy |
| 04/14/2023 | 231.49% | HC Wainwright & Co. | $3 → $18 | Maintains | Buy |
| 08/26/2022 | -44.75% | HC Wainwright & Co. | $4 → $3 | Maintains | Buy |
| 01/03/2022 | 10.5% | HC Wainwright & Co. | $7 → $6 | Maintains | Buy |
| 06/01/2021 | 28.91% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
| 05/11/2021 | -17.13% | Lake Street | → $4.5 | Initiates Coverage On | → Buy |
| 02/09/2021 | 10.5% | HC Wainwright & Co. | $8 → $6 | Maintains | Buy |
| 11/30/2020 | 84.16% | HC Wainwright & Co. | $12 → $10 | Maintains | Buy |
| 08/17/2020 | 120.99% | HC Wainwright & Co. | $14 → $12 | Maintains | Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 2023 年 7 月 24 日 | 176.24% | HC Wainwright & Co. | → 15 美元 | 重申 | 購買 → 購買 |
| 06/05/2023 | 176.24% | HC Wainwright & Co. | 18 美元 → 15 美元 | 維護 | 購買 |
| 04/14/2023 | 231.49% | HC Wainwright & Co. | 3 美元 → 18 美元 | 維護 | 購買 |
| 2022 年 8 月 26 日 | -44.75% | HC Wainwright & Co. | 4 美元 → 3 美元 | 維護 | 購買 |
| 01/03/2022 | 10.5% | HC Wainwright & Co. | 7 美元 → 6 美元 | 維護 | 購買 |
| 06/01/2021 | 28.91% | HC Wainwright & Co. | 6 美元 → 7 美元 | 維護 | 購買 |
| 05/11/2021 | -17.13% | 湖街 | → 4.5 美元 | 啓動覆蓋開啓 | → 購買 |
| 02/09/2021 | 10.5% | HC Wainwright & Co. | 8 美元 → 6 美元 | 維護 | 購買 |
| 11/30/2020 | 84.16% | HC Wainwright & Co. | 12 美元 → 10 美元 | 維護 | 購買 |
| 2020 年 8 月 17 日 | 120.99% | HC Wainwright & Co. | 14 美元 → 12 美元 | 維護 | 購買 |
What is the target price for Arcadia Biosciences (RKDA)?
Arcadia Biosciences（RKDA）的目標價格是多少？
The latest price target for Arcadia Biosciences (NASDAQ: RKDA) was reported by HC Wainwright & Co. on July 24, 2023. The analyst firm set a price target for $15.00 expecting RKDA to rise to within 12 months (a possible 176.24% upside). 4 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年7月24日公佈了Arcadia Biosciences（納斯達克股票代碼：RKDA）的最新目標股價。這家分析公司將目標股價定爲15.00美元，預計RKDA將在12個月內升至15.00美元（可能上漲176.24％）。去年有4家分析公司公佈了評級。
What is the most recent analyst rating for Arcadia Biosciences (RKDA)?
Arcadia Biosciences（RKDA）的最新分析師評級是多少？
The latest analyst rating for Arcadia Biosciences (NASDAQ: RKDA) was provided by HC Wainwright & Co., and Arcadia Biosciences reiterated their buy rating.
Arcadia Biosciences（納斯達克股票代碼：RKDA）的最新分析師評級由HC Wainwright & Co. 提供，Arcadia Biosciences 重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Arcadia Biosciences (RKDA)?
Arcadia Biosciences（RKDA）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Arcadia Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Arcadia Biosciences was filed on July 24, 2023 so you should expect the next rating to be made available sometime around July 24, 2024.
分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與Arcadia Biosciences的高管和客戶交談以及聽取財報電話會議）後得出股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Arcadia Biosciences的最新評級是在2023年7月24日提交的，因此您應該預計下一個評級將在2024年7月24日左右公佈。
Is the Analyst Rating Arcadia Biosciences (RKDA) correct?
分析師對Arcadia Biosciences（RKDA）的評級正確嗎？
While ratings are subjective and will change, the latest Arcadia Biosciences (RKDA) rating was a reiterated with a price target of $0.00 to $15.00. The current price Arcadia Biosciences (RKDA) is trading at is $5.43, which is within the analyst's predicted range.
儘管評級是主觀的，將會發生變化，但最新的Arcadia Biosciences（RKDA）評級得到重申，目標股價爲0.00美元至15.00美元。Arcadia Biosciences（RKDA）目前的交易價格爲5.43美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。
